FACTANKER · measured, cited, anchored official records connected

Amgen Inc. — Operating Income by Fiscal Year

19 fiscal years, as filed with the SEC; every row links its evidence fact.

Cite as: FACTANKER, https://factanker.com/entity/f2a459bc-74cd-41a8-8f2b-b171e94c495e/serie/operating-income

Fiscal yearOperating IncomePeriodEvidence
FY 2025$9.1B2025-01-01 – 2025-12-31evidence 0000318154-26-000010
FY 2024$7.3B2024-01-01 – 2024-12-31evidence 0000318154-25-000010
FY 2023$7.9B2023-01-01 – 2023-12-31evidence 0000318154-24-000011
FY 2022$9.6B2022-01-01 – 2022-12-31evidence 0000318154-23-000017
FY 2021$7.6B2021-01-01 – 2021-12-31evidence 0000318154-22-000010
FY 2020$9.1B2020-01-01 – 2020-12-31evidence 0000318154-21-000010
FY 2019$9.7B2019-01-01 – 2019-12-31evidence 0000318154-20-000017
FY 2018$10.3B2018-01-01 – 2018-12-31evidence 0000318154-19-000008
FY 2017$10.0B2017-01-01 – 2017-12-31evidence 0000318154-18-000004
FY 2016$9.8B2016-01-01 – 2016-12-31evidence 0000318154-17-000004
FY 2015$8.5B2015-01-01 – 2015-12-31evidence 0000318154-16-000031
FY 2014$6.2B2014-01-01 – 2014-12-31evidence 0000318154-15-000005
FY 2013$5.9B2013-01-01 – 2013-12-31evidence 0000318154-14-000004
FY 2012$5.6B2012-01-01 – 2012-12-31evidence 0001445305-13-000364
FY 2011$4.3B2011-01-01 – 2011-12-31evidence 0001193125-12-086670
FY 2010$5.5B2010-01-01 – 2010-12-31evidence 0000950123-11-018800
FY 2009$5.5B2009-01-01 – 2009-12-31evidence 0001193125-10-044311
FY 2008$5.2B2008-01-01 – 2008-12-31evidence 0001193125-10-044311
FY 2007$4.0B2007-01-01 – 2007-12-31evidence 0001193125-10-044311
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).

Amgen Inc. — all facts · Revenue · Net Income